These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 28413156)

  • 21. Nitration of tau protein is linked to neurodegeneration in tauopathies.
    Horiguchi T; Uryu K; Giasson BI; Ischiropoulos H; LightFoot R; Bellmann C; Richter-Landsberg C; Lee VM; Trojanowski JQ
    Am J Pathol; 2003 Sep; 163(3):1021-31. PubMed ID: 12937143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
    Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Untangling the tauopathies: Current concepts of tau pathology and neurodegeneration.
    Ling H
    Parkinsonism Relat Disord; 2018 Jan; 46 Suppl 1():S34-S38. PubMed ID: 28789904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau pathology in Alzheimer disease and other tauopathies.
    Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.
    Narasimhan S; Guo JL; Changolkar L; Stieber A; McBride JD; Silva LV; He Z; Zhang B; Gathagan RJ; Trojanowski JQ; Lee VMY
    J Neurosci; 2017 Nov; 37(47):11406-11423. PubMed ID: 29054878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases.
    Kanaan NM; Morfini GA; LaPointe NE; Pigino GF; Patterson KR; Song Y; Andreadis A; Fu Y; Brady ST; Binder LI
    J Neurosci; 2011 Jul; 31(27):9858-68. PubMed ID: 21734277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy.
    Piras A; Collin L; Grüninger F; Graff C; Rönnbäck A
    Acta Neuropathol Commun; 2016 Mar; 4():22. PubMed ID: 26936765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thioflavin S Staining and Amyloid Formation Are Unique to Mixed Tauopathies.
    Fiock KL; Betters RK; Hefti MM
    J Histochem Cytochem; 2023 Feb; 71(2):73-86. PubMed ID: 36861683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review.
    Gibbons GS; Lee VMY; Trojanowski JQ
    JAMA Neurol; 2019 Jan; 76(1):101-108. PubMed ID: 30193298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
    Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Blanco R; Carmona M; Puig B
    Neuropathol Appl Neurobiol; 2001 Oct; 27(5):343-51. PubMed ID: 11679086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease.
    Neumann M; Müller V; Görner K; Kretzschmar HA; Haass C; Kahle PJ
    Acta Neuropathol; 2004 Jun; 107(6):489-96. PubMed ID: 14991385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies.
    Spina S; Brown JA; Deng J; Gardner RC; Nana AL; Hwang JL; Gaus SE; Huang EJ; Kramer JH; Rosen HJ; Kornak J; Neuhaus J; Miller BL; Grinberg LT; Boxer AL; Seeley WW
    Brain; 2019 Jul; 142(7):2068-2081. PubMed ID: 31081015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies.
    Rockenstein E; Ubhi K; Mante M; Florio J; Adame A; Winter S; Brandstaetter H; Meier D; Masliah E
    BMC Neurosci; 2015 Nov; 16():85. PubMed ID: 26611895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities.
    Mailliot C; Bussière T; Hamdane M; Sergeant N; Caillet ML; Delacourte A; Buée L
    Ann N Y Acad Sci; 2000; 920():107-14. PubMed ID: 11193138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tauopathies.
    Kovacs GG
    Handb Clin Neurol; 2017; 145():355-368. PubMed ID: 28987182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau.
    Taniguchi-Watanabe S; Arai T; Kametani F; Nonaka T; Masuda-Suzukake M; Tarutani A; Murayama S; Saito Y; Arima K; Yoshida M; Akiyama H; Robinson A; Mann DMA; Iwatsubo T; Hasegawa M
    Acta Neuropathol; 2016 Feb; 131(2):267-280. PubMed ID: 26538150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Function and regulation of cis P-tau in the pathogenesis and treatment of conventional and nonconventional tauopathies.
    Wang R; Lu KP; Zhou XZ
    J Neurochem; 2023 Sep; 166(6):904-914. PubMed ID: 37638382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuronal subpopulations and genetic background in tauopathies: a catch 22 story?
    Buée L; Delacourte A; Wilhelmsen KC; Miller B; Geschwind D
    Neurobiol Aging; 2001; 22(1):115-21. PubMed ID: 11164283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.